BIOMAT Database Logo BIOMAT Database Logo

Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis. 1982

T Hibi, and S Aiso, and T Yoshida, and M Watanabe, and H Asakura, and S Tsuru, and M Tsuchiya

The presence of anti-colon antibody in the sera from patients with ulcerative colitis was demonstrated by antibody-dependent cell-mediated cytotoxicity (ADCC) assay. In addition, the high prevalence of lymphocytophilic antibody in the sera from patients with ulcerative colitis was obtained by fluorescence activated cell sorter (FACS) analysis. This lymphocytophilic antibody was absorbed by rat colon epithelial cells. Moreover the lymphocytes from ulcerative colitis showed lower binding capacity to this antibody, but acquired higher binding capacity after 20 hr incubation at 37 degrees C in vitro. These data suggest that ADCC may have some role in the pathogenesis of ulcerative colitis.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D003106 Colon The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON. Appendix Epiploica,Taenia Coli,Omental Appendices,Omental Appendix,Appendices, Omental,Appendix, Omental
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

T Hibi, and S Aiso, and T Yoshida, and M Watanabe, and H Asakura, and S Tsuru, and M Tsuchiya
[Analysis of anticolon antibody and lymphocytophilic antibody in sera from patients with ulcerative colitis].
March 1985, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
T Hibi, and S Aiso, and T Yoshida, and M Watanabe, and H Asakura, and S Tsuru, and M Tsuchiya
Anti-colon antibodies in ulcerative colitis. A clinical study.
January 1976, Scandinavian journal of gastroenterology,
T Hibi, and S Aiso, and T Yoshida, and M Watanabe, and H Asakura, and S Tsuru, and M Tsuchiya
Fluorescent anti-colon and organ-specific antibodies in ulcerative colitis.
January 1973, Scandinavian journal of gastroenterology,
T Hibi, and S Aiso, and T Yoshida, and M Watanabe, and H Asakura, and S Tsuru, and M Tsuchiya
Histological liver disorder and anti-colon antibodies in ulcerative colitis.
November 1974, Acta pathologica et microbiologica Scandinavica. Section A, Pathology,
T Hibi, and S Aiso, and T Yoshida, and M Watanabe, and H Asakura, and S Tsuru, and M Tsuchiya
Fluorescent anti-colon antibodies and inflammatory eosinophilia in ulcerative colitis.
January 1974, Scandinavian journal of gastroenterology,
T Hibi, and S Aiso, and T Yoshida, and M Watanabe, and H Asakura, and S Tsuru, and M Tsuchiya
Ulcerative colitis and colon cancer.
December 1988, Gastroenterology clinics of North America,
T Hibi, and S Aiso, and T Yoshida, and M Watanabe, and H Asakura, and S Tsuru, and M Tsuchiya
Colon cancer in ulcerative colitis.
April 1988, Gastroenterology,
T Hibi, and S Aiso, and T Yoshida, and M Watanabe, and H Asakura, and S Tsuru, and M Tsuchiya
Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice.
January 2017, Frontiers in immunology,
T Hibi, and S Aiso, and T Yoshida, and M Watanabe, and H Asakura, and S Tsuru, and M Tsuchiya
Colon cancers and pseudopolyps in ulcerative colitis.
October 1965, American journal of proctology,
T Hibi, and S Aiso, and T Yoshida, and M Watanabe, and H Asakura, and S Tsuru, and M Tsuchiya
Autoantibodies to colon in ulcerative colitis.
February 1969, British medical journal,
Copied contents to your clipboard!